Brief: Adocia Announces Expanded Biochaperone Product Portfolio Beyond Diabetes

Adocia SA

04/01/2018 17:01

Jan 4 (Reuters) - ADOCIA SA  ADOC.PA : 
    * ADOCIA ANNOUNCES EXPANDED BIOCHAPERONE PRODUCT PORTFOLIO 
BEYOND 
DIABETES 
    * BIOCHAPERONE TO BE DEPLOYED IN SELECTED RANGE OF 
INJECTABLE 
THERAPEUTICS ACROSS NUMEROUS THERAPEUTIC AREAS 
    * INITIAL PROGRAMS ADDED INCLUDE READY-TO-INJECT VERSION OF 
TEDUGLUTIDE FOR TREATMENT OF SHORT BOWEL SYNDROME 
    * INITIAL PROGRAMS ADDED INCLUDE FIXED DOSE COMBINATION OF 
GLUCAGON AND EXENATIDE FOR TREATMENT OF OBESITY 
    * EXPANSION OF PORTFOLIO CREATES NEW PARTNERSHIP 
OPPORTUNITIES 
 
Source text for Eikon:  ID:nBwW5byGa  
Further company coverage:  ADOC.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))